A critical role for HER3 in HER2-amplified and non-amplified breast cancers: function of a kinase-dead RTK

Por Dey, Nandini, Williams, Casey, Leyland-Jones, Brain, De, Pradip
Publicado no Am J Transl Res (2015)

Clinical outcomes of gastrointestinal brain metastases treated with radiotherapy

Por Sanghvi, Samrat M., Lischalk, Jonathan W., Cai, Ling, Collins, Sean, Nair, Mani, Collins, Brain, Unger, Keith
Publicado no Radiat Oncol (2017)

Assessment of circulating tumor cells and serum markers for progression-free survival prediction in metastatic breast cancer: a prospective observational study

Por Bidard, François-Clément, Hajage, David, Bachelot, Thomas, Delaloge, Suzette, Brain, Etienne, Campone, Mario, Cottu, Paul, Beuzeboc, Philippe, Rolland, Emilie, Mathiot, Claire, Pierga, Jean-Yves
Publicado em 2012

First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity

Por Brignone, Chrystelle, Gutierrez, Maya, Mefti, Fawzia, Brain, Etienne, Jarcau, Rosana, Cvitkovic, Frédérique, Bousetta, Nabil, Medioni, Jacques, Gligorov, Joseph, Grygar, Caroline, Marcu, Manon, Triebel, Frédéric
Publicado em 2010

It Is Time to Include Patients With Brain Tumors in Phase I Trials in Oncology

Por Wen, Patrick Y., Schiff, David, Cloughesy, Timothy F., Reardon, David A., Batchelor, Tracy T., Chabner, Bruce A., Flaherty, Keith, de Groot, John F., Gilbert, Mark R., Galanis, Evanthia, Chang, Susan M., Schwartz, Gary K., Peereboom, David, Mehta, Minesh P., Yung, W.K. Alfred, Grossman, Stuart A., Prados, Michael D., DeAngelis, Lisa M.
Publicado no J Clin Oncol (2011)

Phase 1 trial of dichloroacetate (DCA) in adults with recurrent malignant brain tumors

Por Dunbar, E. M., Coats, B. S., Shroads, A. L., Langaee, T., Lew, A., Forder, J. R., Shuster, J. J., Wagner, D. A., Stacpoole, P. W.
Publicado no Invest New Drugs (2013)

PDCT-12. A PHASE I TRIAL OF TUMOR TREATING FIELDS WITH AND WITHOUT CONCOMITANT TEMOZOLOMIDE...

Por Hanson, Derek
Publicado no Neuro Oncol (2018)

Recurrent Glioblastoma Treated with Bevacizumab: Contrast-enhanced T1-weighted Subtraction Maps...

Por Ellingson, Benjamin M., Kim, Hyun J., Woodworth, Davis C., Pope, Whitney B., Cloughesy, Jonathan N., Harris, Robert J., Lai, Albert, Nghiemphu, Phioanh L., Cloughesy, Timothy F.
Publicado no Radiology (2014)

Phase I Trial of Lapatinib in Children With Refractory CNS Malignancies: A Pediatric Brain Tumor Consortium Study

Por Fouladi, Maryam, Stewart, Clinton. F., Blaney, Susan M., Onar-Thomas, Arzu, Schaiquevich, Paula, Packer, Roger J., Gajjar, Amar, Kun, Larry E., Boyett, James M., Gilbertson, Richard J.
Publicado em 2010

A phase I trial of veliparib (ABT-888) and temozolomide in children with recurrent CNS tumors: a Pediatric Brain Tumor Consortium report(†)

Por Su, Jack M., Thompson, Patrick, Adesina, Adekunle, Li, Xiao-Nan, Kilburn, Lindsay, Onar-Thomas, Arzu, Kocak, Mehmet, Chyla, Brenda, McKeegan, Evelyn, Warren, Katherine E., Goldman, Stewart, Pollack, Ian F., Fouladi, Maryam, Chen, Alice, Giranda, Vincent, Boyett, James, Kun, Larry, Blaney, Susan M.
Publicado no Neuro Oncol (2014)

Phase 1 trial and pharmacokinetic study of the oral platinum analog satraplatin in children...

Por Akshintala, Srivandana, Marcus, Leigh, Warren, Katherine E., Murphy, Robert F., Sissung, Tristan M., Srivastava, Anjali, Goodspeed, Wendy J., Goodwin, Anne, Brewer, Carmen C., Zalewski, Christopher, King, Kelly A., Kim, AeRang, Figg, William D., Widemann, Brigitte C.
Publicado no Pediatr Blood Cancer (2015)

Phase I Trial of MK-0752 in Children With Refractory CNS Malignancies: A Pediatric Brain Tumor Consortium Study

Por Fouladi, Maryam, Stewart, Clinton F., Olson, James, Wagner, Lars M., Onar-Thomas, Arzu, Kocak, Mehmet, Packer, Roger J., Goldman, Stewart, Gururangan, Sridharan, Gajjar, Amar, Demuth, Tim, Kun, Larry E., Boyett, James M., Gilbertson, Richard J.
Publicado em 2011

Phase-1 trial of gefitinib and temozolomide in patients with malignant glioma: a North American brain tumor consortium study

Por Prados, Michael D., Yung, W. K. A., Wen, Patrick Y., Junck, Larry, Cloughesy, Timothy, Fink, Karen, Chang, Susan, Robins, H. Ian, Dancey, Janet, Kuhn, John
Publicado em 2007

Phase I Trial of Lenalidomide in Pediatric Patients With Recurrent, Refractory, or Progressive...

Por Warren, Katherine E., Goldman, Stewart, Pollack, Ian F., Fangusaro, Jason, Schaiquevich, Paula, Stewart, Clinton F., Wallace, Dana, Blaney, Susan M., Packer, Roger, MacDonald, Tobey, Jakacki, Regina, Boyett, James M., Kun, Larry E.
Publicado em 2011

A phase I trial of 1,3-bis(2-chloroethyl)-1-nitrosourea plus temozolomide: a North American Brain Tumor Consortium study.

Por Schold, S. C., Kuhn, J. G., Chang, S. M., Bosik, M. E., Robins, H. I., Mehta, M. P., Spence, A. M., Fulton, D., Fink, K. L., Prados, M. D.
Publicado em 2000

Shiga toxin 1 induces on lipopolysaccharide-treated astrocytes the release of tumor necrosis factor-alpha that alter brain-like endothelium integrity.

Por Verónica I Landoni, Pablo Schierloh, Marcelo de Campos Nebel, Gabriela C Fernández, Cecilia Calatayud, María J Lapponi, Martín A Isturiz
Publicado em 2012-01-01

Shiga Toxin 1 Induces on Lipopolysaccharide-Treated Astrocytes the Release of Tumor Necrosis Factor-alpha that Alter Brain-Like Endothelium Integrity

Por Landoni, Verónica I., Schierloh, Pablo, de Campos Nebel, Marcelo, Fernández, Gabriela C., Calatayud, Cecilia, Lapponi, María J., Isturiz, Martín A.
Publicado em 2012

ATNT-20 A PHASE I-II TRIAL EVEROLIMUS AND SORAFENIB IN PATIENTS WITH RECURRENT HIGH-GRADE GLIOMAS: BRAIN TUMOR TREATMENT COLLABORATIVE TRIAL 09-01

Por Raizer, Jeffrey, Grimm, Sean, Penas-Prado, Marta, Tremont-Lukats, Ivo, Yung, Alfred, Avgeropoulos, Nicholas, Walbert, Tobias, Loghin, Monica, Gilbert, Mark
Publicado no Neuro Oncol (2015)

RBTT-05. TUMOR TREATING FIELDS AND RADIOSURGERY FOR SUPRA- AND/OR INFRATENTORIAL BRAIN METASTASES (1–10) FROM NSCLC IN THE PHASE 3 METIS STUDY

Por P Mehta, Minesh, Gondi, Vinai, Ahluwalia, Manmeet, D Brown, Paul
Publicado no Neuro Oncol (2018)

Phase 1 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: A North American Brain Tumor Consortium study

Por Prados, Michael D., Yung, W.K.A., Jaeckle, Kurt A., Robins, H. Ian, Mehta, Minesh P., Fine, Howard A., Wen, Patrick Y., Cloughesy, Timothy F., Chang, Susan M., Nicholas, M. Kelly, Schiff, David, Greenberg, Harry S., Junck, Larry, Fink, Karen L., Hess, Kenneth R., Kuhn, John
Publicado em 2004